[{"address1": "B\u00e2timent IRO", "address2": "107 Av. de la R\u00e9publique", "city": "Ch\u00e2tillon", "zip": "92320", "country": "France", "phone": "33 1 55 42 78 78", "website": "https://www.dbv-technologies.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestl\u00e9 Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Ch\u00e2tillon, France.", "fullTimeEmployees": 106, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel  Tass\u00e9", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 984020, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Virginie Simone Jeanine Verrechia Boucinha M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2024, "totalPay": 404427, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pharis  Mohideen M.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 718591, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevin P. Malobisky M.S., Ph.D., R.A.C.", "title": "Chief Operations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele F. Robertson", "title": "Chief Legal Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Daniere", "age": 50, "title": "Chief Human Resources Officer & Chief of Staff", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Alan  Kerr", "title": "Senior VP & Head of Global Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Pascal  Wotling", "title": "Chief External Manufacturing & Supply Chain Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert G. Pietrusko Pharm. D., Pharm.D.", "age": 76, "title": "Chief Regulatory Officer", "yearBorn": 1948, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Matthews", "title": "Investor Relations Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.71, "open": 9.8, "dayLow": 9.8, "dayHigh": 10.3743, "regularMarketPreviousClose": 9.71, "regularMarketOpen": 9.8, "regularMarketDayLow": 9.8, "regularMarketDayHigh": 10.3743, "payoutRatio": 0.0, "beta": 0.319, "forwardPE": -9.345794, "volume": 55345, "regularMarketVolume": 55345, "averageVolume": 62322, "averageVolume10days": 16300, "averageDailyVolume10Day": 16300, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 273476992, "fiftyTwoWeekLow": 0.441, "fiftyTwoWeekHigh": 12.78, "priceToSalesTrailing12Months": 78.203316, "fiftyDayAverage": 9.62578, "twoHundredDayAverage": 5.278595, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1246598528, "profitMargins": 0.0, "floatShares": 65520906, "sharesOutstanding": 27347700, "sharesShort": 21988, "sharesShortPriorMonth": 95156, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.01811, "shortRatio": 0.3, "shortPercentOfFloat": 0.0011, "impliedSharesOutstanding": 23005100, "bookValue": 0.028, "priceToBook": 357.14285, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -113652000, "trailingEps": -5.75, "forwardEps": -1.07, "lastSplitFactor": "1:2", "lastSplitDate": 1717718400, "enterpriseToRevenue": 356.477, "52WeekChange": 9.822511, "SandP52WeekChange": 0.13161862, "quoteType": "EQUITY", "currentPrice": 10.0, "targetHighPrice": 20.985245, "targetLowPrice": 7.457883, "targetMeanPrice": 15.955907, "targetMedianPrice": 17.69025, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 12962000, "totalCashPerShare": 0.095, "totalDebt": 7234000, "quickRatio": 0.626, "currentRatio": 0.722, "totalRevenue": 3497000, "debtToEquity": 251.793, "revenuePerShare": 0.175, "returnOnAssets": -0.72947997, "returnOnEquity": -1.98472, "grossProfits": 3497000, "freeCashflow": -53076752, "operatingCashflow": -89450000, "revenueGrowth": -0.465, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -35.34927, "financialCurrency": "USD", "symbol": "DBVT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_7406282", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.9866114, "regularMarketPrice": 10.0, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1413984600000, "postMarketChangePercent": -0.299997, "postMarketPrice": 9.97, "postMarketChange": -0.0299997, "regularMarketChange": 0.28999996, "regularMarketDayRange": "9.8 - 10.3743", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 62322, "fiftyTwoWeekLowChange": 9.559, "fiftyTwoWeekLowChangePercent": 21.675735, "fiftyTwoWeekRange": "0.441 - 12.78", "fiftyTwoWeekHighChange": -2.7799997, "fiftyTwoWeekHighChangePercent": -0.21752737, "fiftyTwoWeekChangePercent": 982.2511, "earningsTimestamp": 1746043200, "earningsTimestampStart": 1753700340, "earningsTimestampEnd": 1754049600, "earningsCallTimestampStart": 1722375000, "earningsCallTimestampEnd": 1722375000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.75, "epsForward": -1.07, "corporateActions": [], "postMarketTime": 1752868843, "regularMarketTime": 1752868800, "marketState": "CLOSED", "shortName": "DBV Technologies S.A.", "longName": "DBV Technologies S.A.", "epsCurrentYear": -0.811, "priceEpsCurrentYear": -12.330457, "fiftyDayAverageChange": 0.3742199, "fiftyDayAverageChangePercent": 0.03887684, "twoHundredDayAverageChange": 4.721405, "twoHundredDayAverageChangePercent": 0.8944435, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "DBV", "trailingPegRatio": null, "__fetch_time": "2025-07-19"}]